New hope for nasal polyp sufferers: Long-Term drug safety trial launches
NCT ID NCT06914908
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study looks at the long-term safety and effectiveness of a drug called lunsekimig in adults with chronic sinusitis and nasal polyps that are not well controlled. Participants must have completed a previous lunsekimig study. The trial lasts about 56 weeks and measures side effects and symptom changes using questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alamo ENT Associates- Site Number : 8400001
San Antonio, Texas, 78258, United States
-
ENT Associates of Texas - McKinne- Site Number : 8400014
McKinney, Texas, 75070, United States
-
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400008
Norfolk, Virginia, 23510, United States
-
Essential Medical Research- Site Number : 8400020
Tulsa, Oklahoma, 74137, United States
-
Investigational Site Number : 0320001
Buenos Aires, 1121, Argentina
-
Investigational Site Number : 0320002
Rosario, Santa Fe Province, 2000, Argentina
-
Investigational Site Number : 0320003
Mendoza, 5500, Argentina
-
Investigational Site Number : 0560001
Leuven, 3000, Belgium
-
Investigational Site Number : 0560002
Ghent, 9000, Belgium
-
Investigational Site Number : 1000001
Sofia, 1612, Bulgaria
-
Investigational Site Number : 6160001
Warsaw, Masovian Voivodeship, 00-909, Poland
-
Investigational Site Number : 6160002
Krakow, Lesser Poland Voivodeship, 30-033, Poland
-
Investigational Site Number : 6160003
Katowice, Silesian Voivodeship, 40-611, Poland
-
Investigational Site Number : 6160004
Poznan, Greater Poland Voivodeship, 60-693, Poland
-
Investigational Site Number : 6160005
Warsaw, Masovian Voivodeship, 02-507, Poland
-
Investigational Site Number : 6160007
Wroclaw, Lower Silesian Voivodeship, 50-750, Poland
-
Investigational Site Number : 8260001
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Investigational Site Number : 8260003
Manchester, M13 9wl, United Kingdom
-
Investigational Site Number : 8260004
Gloucester, Gloucestershire, GL1 3NN, United Kingdom
-
McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8400017
Bellaire, Texas, 77401, United States
-
Modena Allergy + Asthma- Site Number : 8400005
La Jolla, California, 92037, United States
-
Pharmaceutical Research & Consulting- Site Number : 8400004
Dallas, Texas, 75231, United States
-
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400003
Roseville, California, 95661, United States
-
Treasure Valley Medical Research- Site Number : 8400002
Boise, Idaho, 83706, United States
Conditions
Explore the condition pages connected to this study.